A Study of MSB2311 in Advanced Solid Tumors

Clinical trial NCT04272944 · COMPLETED

Trial details

NCT number: NCT04272944
Sponsor: Suzhou Transcenta Therapeutics Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2018-08-13
Primary completion: 2022-01-31
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.